VIDAR-1 trial marks company’s clinical-stage debut
A study shows that high-grade glioma tumor cells harboring DNA alterations in the gene PDGFRA responded to the […]
Updated Date: Mon, 10 Mar 2025 00:00:00 EDT
Updated Date: Mon, 10 Mar 2025 00:00:00 EDT
Updated Date: Mon, 10 Mar 2025 00:00:00 EDT
Updated Date: Mon, 10 Mar 2025 00:00:00 EDT
Updated Date: Mon, 10 Mar 2025 00:00:00 EDT
EC extends brexpiprazole indication to include adolescents
Immunoglobulin therapy improves mobility in phase 2/3 study
